Assessment of tumour-agnostic therapies in basket trials

Lancet Oncol. 2022 Jan;23(1):e8. doi: 10.1016/S1470-2045(21)00717-8.

Authors

Olivier Collignon¹, Martin Posch², Anja Schiel³

Affiliations

¹ GlaxoSmithKline, Speciality and Primary Care Statistics, Hertfordshire SG1 2NY, UK. Electronic address: [email protected].
² Section for Medical Statistics, Center for Medical Statistics, Informatics, and Intelligent Systems, Medical University of Vienna, Vienna, Austria.
³ Norwegian Medicines Agency, Oslo, Norway.

PMID: 34973235
DOI: 10.1016/S1470-2045(21)00717-8

No abstract available

Publication types

Letter
Research Support, Non-U.S. Gov't
Comment

MeSH terms

Humans
Molecular Targeted Therapy
Neoplasms* / drug therapy